Giovanni Marco Saladino, a postdoctoral scholar at Stanford University, is developing innovative multimodal nanoparticles that enable simultaneous imaging via MRI and X-ray fluorescence. These engineered contrast agents provide precise, real-time tracking of therapeutic particles in vivo, enhancing both diagnostic and treatment monitoring capabilities. His interdisciplinary approach bridges physics, chemistry, and medicine to impact nanomedicine and molecular imaging fields significantly.